Colorectal Surgery Review

Focuses on distinguishing and managing Irritable Bowel Syndrome using the rigid Rome IV criteria. It issues a stark warning against operating on functional visceral hypersensitivity, detailing how elective resections for symptomatic uncomplicated diverticular disease frequently fail to relieve pain. The episode reviews targeted pharmacotherapy based on IBS subtypes (e.g., eluxadoline for IBS-D and lubiprostone for IBS-C), and addresses pelvic floor pain syndromes like proctalgia fugax, which surprisingly responds to inhaled albuterol.

Tackles the inevitable biomechanical failure of parastomal hernias, which eventually affect nearly all permanent stoma patients. It emphasizes strict preoperative optimization goals, including a BMI under 35, an A1C under 8, and absolute smoking cessation. The discussion covers the mechanical superiority of the Sugarbaker mesh drape geometry over the keyhole technique, and explores advanced retromuscular/TAR (Transversus Abdominis Release) approaches utilizing macroporous uncoated synthetic mesh in contaminated fields.

A comprehensive guide to the physiological and mechanical management of stomas. Key topics include the massive clinical and financial benefits of preoperative WOCN education, and advanced troubleshooting for stoma complications like peristomal pyoderma gangrenosum and bleeding parastomal varices. The episode explores the exact sodium-glucose transporter (SGLT1) mechanics that make WHO oral rehydration solutions essential for high-output stomas, and reviews evolving trial data challenging the traditional 12-week wait period for stoma reversals.

This episode unpacks three deceptive colitis presentations. For chronic radiation proctitis, driven by obliterative endarteritis, the biggest takeaway is strictly avoiding mucosal biopsies to prevent catastrophic fistulas. Microscopic colitis (collagenous and lymphocytic) presents with watery diarrhea and normal gross mucosa, requiring specific targeted biopsies and treatment with budesonide. Finally, ischemic colitis is detailed as a low-flow microvascular event causing superficial necrosis with deep crypt sparing, where primary anastomosis is contraindicated in the acute setting.

A high-yield breakdown of Clostridioides difficile, focusing on the hypervirulent Ribotype 027 strain driving increased hospital morbidity. The episode details the clinical shift away from metronidazole to oral vancomycin or fidaxomicin, and the surprising paradox that mechanical bowel prep with oral antibiotics actually reduces postoperative CDI risk. For surgical management of fulminant colitis, it contrasts the morbidity of the traditional total abdominal colectomy with the colon-preserving loop ileostomy and colonic lavage approach.